Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

BOM Capital

Investor type Government Office


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 97
Average round size
The average size of a deal this fund participated in
Portfolio companies 80
Rounds per year 2.49
Lead investments 17
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 8
Key employees 1
Stages of investment
Early Stage Venture
Private Equity

Areas of investment

  • Manufacturing
  • Health Care
  • Medical
  • Medical Device
  • Biotechnology

BOM Capital is the famous VC, which was founded in 1983. The leading representative office of defined VC is situated in the Tilburg. The fund was located in Europe if to be more exact in The Netherlands.

Opposing the other organizations, this BOM Capital works on 20 percentage points less the average amount of lead investments. The fund is constantly included in 2-6 deals per year. Deals in the range of 5 - 10 millions dollars are the general things for fund. The top activity for fund was in 2015. Despite it in 2019 the fund had an activity. The higher amount of exits for fund were in 2015. The real fund results show that this VC is 5 percentage points more often commits exit comparing to other companies.

The typical case for the fund is to invest in rounds with 1-2 participants. Despite the BOM Capital, startups are often financed by Thuja Capital, EASME - EU Executive Agency for SMEs, Technology Development Fund. The meaningful sponsors for the fund in investment in the same round are Thuja Capital, TIIN Capital, BioGeneration Ventures. In the next rounds fund is usually obtained by EASME - EU Executive Agency for SMEs, BNP Paribas Private Equity, henQ.

The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Information Technology, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - The Netherlands. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight AcertaPharma, Protix Biosystems, ULU.

Besides them, we counted 1 critical employee of this fund in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of BOM Capital:
Typical Co-investors
BOM Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after BOM Capital:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Developer APIs
$8M12 Jul 2022 Barendrecht, Zuid-Holland, The Netherlands

VitalFluid B.V.

Organic Food
$2M24 Jan 2022 Veldhoven, Noord-Brabant, The Netherlands


3D Technology
$4M18 Nov 2021 Eindhoven, Noord-Brabant, The Netherlands

Travis Road Services

Information Technology
$5M08 Nov 2021 Tilburg, North Brabant, Netherlands


3D Technology
$1M05 Aug 2021 Eindhoven, Noord-Brabant, The Netherlands

Onera Health

Medical Device
$12M29 Jul 2021 Palo Alto, California, United States


$14M17 Nov 2020 Eindhoven, North Brabant, Netherlands

Salvia BioElectronics

Medical Device
$31M22 Sep 2020 Eindhoven, North Brabant, Netherlands

Sirius Medical

Health Care
Medical Device
$5M13 Jul 2020 Eindhoven, Noord-Brabant, The Netherlands
Onera raises €10.5M in Series B funding

– Onera closed the Series B funding round, which brought the total funding raised to date above the €24M mark.
Innovation Industries led the round in collaboration with Invest-NL and with existing investors Jazz Pharmaceuticals, imec.xpand, BOM and 15th Rock.
– The company intends to use the funds to execute clinical studies and further commercialize its sleep diagnostics and monitoring products in Europe and the United States.
– Onera recently relocated its headquarters to the Brainport region in Eindhoven, the Netherlands, while maintaining commercial operations in the United States.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent BOM Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: